{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:06:41Z","timestamp":1790204801526,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-024-02234-3","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T08:40:52Z","timestamp":1735202452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of triglyceride glucose\u2013body mass index and left ventricular hypertrophy in patients with IgA nephropathy: a retrospective study"],"prefix":"10.1186","volume":"29","author":[{"given":"Menglei","family":"Jv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anni","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"issue":"5","key":"2234_CR1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.semnephrol.2018.05.015","volume":"38","author":"M Li","year":"2018","unstructured":"Li M, Yu XQ. Genetic determinants of IgA nephropathy: Eastern perspective. Semin Nephrol. 2018;38(5):455\u201360. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.05.015.","journal-title":"Semin Nephrol"},{"issue":"10","key":"2234_CR2","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1093\/ndt\/gfad082","volume":"38","author":"CJ Willey","year":"2023","unstructured":"Willey CJ, Coppo R, Schaefer F, Mizerska-Wasiak M, Mathur M, Schultz MJ. The incidence and prevalence of IgA nephropathy in Europe. Nephrol Dial Transpl. 2023;38(10):2340\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfad082.","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"2234_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2215\/CJN.06980615","volume":"11","author":"E Paoletti","year":"2016","unstructured":"Paoletti E, De Nicola L, Gabbai FB, Chiodini P, Ravera M, Pieracci L, et al. Associations of left ventricular hypertrophy and geometry with adverse outcomes in patients with CKD and hypertension. Clin J Am Soc Nephro. 2016;11(2):271\u20139. https:\/\/doi.org\/10.2215\/CJN.06980615.","journal-title":"Clin J Am Soc Nephro"},{"issue":"6","key":"2234_CR4","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.amjcard.2019.06.003","volume":"124","author":"MI Ahmad","year":"2019","unstructured":"Ahmad MI, Mujtaba M, Anees MA, Li Y, Soliman EZ. Interrelation between electrocardiographic left atrial abnormality, left ventricular hypertrophy, and mortality in participants with hypertension. Am J Cardiol. 2019;124(6):886\u201391. https:\/\/doi.org\/10.1016\/j.amjcard.2019.06.003.","journal-title":"Am J Cardiol"},{"issue":"8","key":"2234_CR5","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s11255-014-0720-3","volume":"46","author":"C Wang","year":"2014","unstructured":"Wang C, Bao X, Du G, Wang Y, Chen K, Shen M, et al. Effects of insulin resistance on left ventricular hypertrophy in patients with CKD stage 1\u20133. Int Urol Nephrol. 2014;46(8):1609\u201317. https:\/\/doi.org\/10.1007\/s11255-014-0720-3.","journal-title":"Int Urol Nephrol"},{"key":"2234_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/691369","volume":"2012","author":"MT Liao","year":"2012","unstructured":"Liao MT, Sung CC, Hung KC, Wu CC, Lo L, Lu KC. Insulin resistance in patients with chronic kidney disease. J Biomed Biotechnol. 2012;2012: 691369. https:\/\/doi.org\/10.1155\/2012\/691369.","journal-title":"J Biomed Biotechnol"},{"issue":"3","key":"2234_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149731","volume":"11","author":"LK Er","year":"2016","unstructured":"Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, et al. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE. 2016;11(3): e0149731. https:\/\/doi.org\/10.1371\/journal.pone.0149731.","journal-title":"PLoS ONE"},{"issue":"1","key":"2234_CR8","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1038\/s41598-021-82053-2","volume":"11","author":"J Lee","year":"2021","unstructured":"Lee J, Kim B, Kim W, Ahn C, Choi HY, Kim JG, et al. Lipid indices as simple and clinically useful surrogate markers for insulin resistance in the U.S. population. Sci Rep-Uk. 2021;11(1):2366. https:\/\/doi.org\/10.1038\/s41598-021-82053-2.","journal-title":"Sci Rep-Uk."},{"issue":"5","key":"2234_CR9","first-page":"587","volume":"11","author":"PB Kianu","year":"2021","unstructured":"Kianu PB, Nkodila NA, Nzundu TA, Kokusa ZR, Limbole BE, Kintoki VE, et al. Insulin resistance-related differences in the relationship between left ventricular hypertrophy and cardiorespiratory fitness in hypertensive Black sub-Saharan Africans. Am J Cardiovasc Dis. 2021;11(5):587\u2013600.","journal-title":"Am J Cardiovasc Dis"},{"issue":"1","key":"2234_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12933-024-02122-4","volume":"23","author":"RR Huo","year":"2024","unstructured":"Huo RR, Liao Q, Zhai L, You XM, Zuo YL. Interacting and joint effects of triglyceride-glucose index (TyG) and body mass index on stroke risk and the mediating role of TyG in middle-aged and older Chinese adults: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23(1):30. https:\/\/doi.org\/10.1186\/s12933-024-02122-4.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2234_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12933-024-02124-2","volume":"23","author":"X Yang","year":"2024","unstructured":"Yang X, Li K, Wen J, Yang C, Li Y, Xu G, et al. Association of the triglyceride glucose-body mass index with the extent of coronary artery disease in patients with acute coronary syndromes. Cardiovasc Diabetol. 2024;23(1):24. https:\/\/doi.org\/10.1186\/s12933-024-02124-2.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2234_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12933-023-02114-w","volume":"23","author":"F Li","year":"2024","unstructured":"Li F, Wang Y, Shi B, Sun S, Wang S, Pang S, et al. Association between the cumulative average triglyceride glucose-body mass index and cardiovascular disease incidence among the middle-aged and older population: a prospective nationwide cohort study in China. Cardiovasc Diabetol. 2024;23(1):16. https:\/\/doi.org\/10.1186\/s12933-023-02114-w.","journal-title":"Cardiovasc Diabetol"},{"key":"2234_CR13","doi-asserted-by":"publisher","DOI":"10.1530\/EC-23-0476","author":"Y Zhai","year":"2024","unstructured":"Zhai Y, Fu H, Li Y, Li S, Zhang W, Yue J, et al. Relationship between four insulin resistance surrogates and left ventricular hypertrophy among hypertensive adults: a case-control study. Endocr Connect. 2024. https:\/\/doi.org\/10.1530\/EC-23-0476.","journal-title":"Endocr Connect"},{"key":"2234_CR14","doi-asserted-by":"publisher","first-page":"1136284","DOI":"10.3389\/fnut.2023.1136284","volume":"10","author":"FC Shen","year":"2023","unstructured":"Shen FC, Lin HY, Tsai WC, Kuo IC, Chen YK, Chao YL, et al. Non-insulin-based insulin resistance indices for predicting all-cause mortality and renal outcomes in patients with stage 1\u20134 chronic kidney disease: another paradox. Front Nutr. 2023;10:1136284. https:\/\/doi.org\/10.3389\/fnut.2023.1136284.","journal-title":"Front Nutr"},{"issue":"1","key":"2234_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12944-023-01892-2","volume":"22","author":"C Zhan","year":"2023","unstructured":"Zhan C, Peng Y, Ye H, Diao X, Yi C, Guo Q, et al. Triglyceride glucose-body mass index and cardiovascular mortality in patients undergoing peritoneal dialysis: a retrospective cohort study. Lipids Health Dis. 2023;22(1):143. https:\/\/doi.org\/10.1186\/s12944-023-01892-2.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"2234_CR16","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","volume":"2","author":"NB Schiller","year":"1989","unstructured":"Schiller NB, Shah PM, Crawford M, Demaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiog. 1989;2(5):358\u201367. https:\/\/doi.org\/10.1016\/S0894-7317(89)80014-8.","journal-title":"J Am Soc Echocardiog"},{"issue":"1","key":"2234_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41440-022-01075-z","volume":"46","author":"S Cai","year":"2023","unstructured":"Cai S, Zhu T, Ding Y, Cheng B, Zhang A, Bao Q, et al. The relationship between the weight-adjusted-waist index and left ventricular hypertrophy in Chinese hypertension adults. Hypertens Res. 2023;46(1):253\u201360. https:\/\/doi.org\/10.1038\/s41440-022-01075-z.","journal-title":"Hypertens Res"},{"issue":"1","key":"2234_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiog. 2015;28(1):1-39.e14. https:\/\/doi.org\/10.1016\/j.echo.2014.10.003.","journal-title":"J Am Soc Echocardiog"},{"issue":"5","key":"2234_CR19","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/0735-1097(94)00540-7","volume":"25","author":"G de Simone","year":"1995","unstructured":"de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol. 1995;25(5):1056\u201362. https:\/\/doi.org\/10.1016\/0735-1097(94)00540-7.","journal-title":"J Am Coll Cardiol"},{"key":"2234_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86693-2","author":"P Viwatrangkul","year":"2021","unstructured":"Viwatrangkul P, Lawanwisut S, Leekhaphan P, Prasart-Intara T, Phiensuparp P, Prakiatpongsa S, et al. Prevalence and associated factors of electrocardiographic left ventricular hypertrophy in a rural community, central Thailand. Sci Rep-Uk. 2021. https:\/\/doi.org\/10.1038\/s41598-021-86693-2.","journal-title":"Sci Rep-Uk."},{"issue":"3","key":"2234_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40292-018-0267-y","volume":"25","author":"MP Baldo","year":"2018","unstructured":"Baldo MP, Gon\u00e7alves MA, Capingana DP, Magalh\u00e3es P, Da Silva ABT, Mill JG. Prevalence and clinical correlates of left ventricular hypertrophy in Black Africans. High Blood Press Car. 2018;25(3):283\u20139. https:\/\/doi.org\/10.1007\/s40292-018-0267-y.","journal-title":"High Blood Press Car"},{"issue":"8","key":"2234_CR22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41371-022-00750-5","volume":"37","author":"C Cuspidi","year":"2023","unstructured":"Cuspidi C, Gherbesi E, Sala C, Tadic M. Sex, gender, and subclinical hypertensiveorgan damage-heart. J Hum Hypertens. 2023;37(8):626\u201333. https:\/\/doi.org\/10.1038\/s41371-022-00750-5.","journal-title":"J Hum Hypertens"},{"issue":"4","key":"2234_CR23","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/HYPERTENSIONAHA.107.107474","volume":"51","author":"E Gerdts","year":"2008","unstructured":"Gerdts E, Okin PM, de Simone G, Cramariuc D, Wachtell K, Boman K, et al. Gender differences in left ventricular structure and function during antihypertensive treatment: the losartan intervention for endpoint reduction in hypertension study. Hypertension (Dallas, Tex 1979). 2008;51(4):1109\u201314. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.107.107474.","journal-title":"Hypertension (Dallas, Tex. 1979)"},{"issue":"6","key":"2234_CR24","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1097\/HJH.0000000000003127","volume":"40","author":"A Cai","year":"2022","unstructured":"Cai A, Liu L, Zhou D, Tang S, Zhou Y, Feng Y. Influences of achieved SBP on age and sex-related left ventricular structural alteration in community hypertensive populations. J Hypertens. 2022;40(6):1170\u20138. https:\/\/doi.org\/10.1097\/HJH.0000000000003127.","journal-title":"J Hypertens"},{"key":"2234_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13098-016-0193-x","volume":"8","author":"G de Simone","year":"2016","unstructured":"de Simone G, Mancusi C, Izzo R, Losi MA, Aldo FL. Obesity and hypertensive heart disease: focus on body composition and sex differences. Diabetol Metab Syndr. 2016;8:79. https:\/\/doi.org\/10.1186\/s13098-016-0193-x.","journal-title":"Diabetol Metab Syndr"},{"key":"2234_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17082811","author":"F Nista","year":"2020","unstructured":"Nista F, Gatto F, Albertelli M, Musso N. Sodium intake and target organ damage in hypertension-an update about the role of a real villain. Int J Env Res Pub He. 2020. https:\/\/doi.org\/10.3390\/ijerph17082811.","journal-title":"Int J Env Res Pub He."},{"key":"2234_CR27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ijcard.2018.11.116","volume":"276","author":"B van der Westhuizen","year":"2019","unstructured":"van der Westhuizen B, Schutte AE, Gafane-Matemane LF, Kruger R. Left ventricular mass independently associates with 24-hour sodium excretion in young masked hypertensive adults: the African-PREDICT study. Int J Cardiol. 2019;276:218\u201323. https:\/\/doi.org\/10.1016\/j.ijcard.2018.11.116.","journal-title":"Int J Cardiol"},{"key":"2234_CR28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fendo.2016.00164","volume":"7","author":"YW Kong","year":"2016","unstructured":"Kong YW, Baqar S, Jerums G, Ekinci EI. Sodium and its role in cardiovascular disease\u2014the debate continues. Front Endocrinol. 2016;7:164. https:\/\/doi.org\/10.3389\/fendo.2016.00164.","journal-title":"Front Endocrinol"},{"issue":"3","key":"2234_CR29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1161\/HYPERTENSIONAHA.110.168054","volume":"58","author":"CJ Rodriguez","year":"2011","unstructured":"Rodriguez CJ, Bibbins-Domingo K, Jin Z, Daviglus ML, Goff DJ, Jacobs DJ. Association of sodium and potassium intake with left ventricular mass: coronary artery risk development in young adults. Hypertension. 2011;58(3):410\u20136. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.168054.","journal-title":"Hypertension"},{"key":"2234_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/nu12123714","author":"N Musso","year":"2020","unstructured":"Musso N, Gatto F, Nista F, Dotto A, Shen Z, Ferone D. Left ventricular mass reduction by a low-sodium diet in treated hypertensive patients. Nutrients. 2020. https:\/\/doi.org\/10.3390\/nu12123714.","journal-title":"Nutrients"},{"key":"2234_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.728493","author":"J Liu","year":"2021","unstructured":"Liu J, Yang X, Zhang P, Guo D, Xu B, Huang C, et al. Association of urinary sodium excretion and left ventricular hypertrophy in people with type 2 diabetes mellitus: a cross-sectional study. Front Endocrinol. 2021. https:\/\/doi.org\/10.3389\/fendo.2021.728493.","journal-title":"Front Endocrinol"},{"issue":"12","key":"2234_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243199","volume":"15","author":"B von Jeinsen","year":"2020","unstructured":"von Jeinsen B, Vasan RS, Mcmanus DD, Mitchell GF, Cheng S, Xanthakis V. Joint influences of obesity, diabetes, and hypertension on indices of ventricular remodeling: findings from the community-based Framingham Heart Study. PLoS ONE. 2020;15(12): e0243199. https:\/\/doi.org\/10.1371\/journal.pone.0243199.","journal-title":"PLoS ONE"},{"issue":"3","key":"2234_CR33","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/s0735-1097(02)01973-3","volume":"40","author":"JM Gardin","year":"2002","unstructured":"Gardin JM, Brunner D, Schreiner PJ, Xie X, Reid CL, Ruth K, et al. Demographics and correlates of five-year change in echocardiographic left ventricular mass in young black and white adult men and women: the coronary artery risk development in young adults (CARDIA) study. J Am Coll Cardiol. 2002;40(3):529\u201335. https:\/\/doi.org\/10.1016\/s0735-1097(02)01973-3.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2234_CR34","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/jhh.2011.104","volume":"26","author":"C Cuspidi","year":"2012","unstructured":"Cuspidi C, Sala C, Negri F, Mancia G, Morganti A. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens. 2012;26(6):343\u20139. https:\/\/doi.org\/10.1038\/jhh.2011.104.","journal-title":"J Hum Hypertens"},{"issue":"10","key":"2234_CR35","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1161\/ATVBAHA.111.231357","volume":"31","author":"M Poggi","year":"2011","unstructured":"Poggi M, Engel D, Christ A, Beckers L, Wijnands E, Boon L, et al. CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice. Arterioscl Throm Vas. 2011;31(10):2251\u201360. https:\/\/doi.org\/10.1161\/ATVBAHA.111.231357.","journal-title":"Arterioscl Throm Vas"},{"issue":"7","key":"2234_CR36","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/s0735-1097(02)02156-3","volume":"40","author":"S Genda","year":"2002","unstructured":"Genda S, Miura T, Miki T, Ichikawa Y, Shimamoto K. K(ATP) channel opening is an endogenous mechanism of protection against the no-reflow phenomenon but its function is compromised by hypercholesterolemia. J Am Coll Cardiol. 2002;40(7):1339\u201346. https:\/\/doi.org\/10.1016\/s0735-1097(02)02156-3.","journal-title":"J Am Coll Cardiol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02234-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-024-02234-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02234-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T09:05:44Z","timestamp":1735203944000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-024-02234-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2234"],"URL":"https:\/\/doi.org\/10.1186\/s40001-024-02234-3","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,26]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the Ethics Committee of the Fifth Affiliated Hospital of Sun Yat-sen University which is followed the guidelines outlined in the Declaration of Helsinki. An exemption for informed consent was applied and approved by the Ethics Committee, because this retrospective study only involved the clinical data and completed test results without any intervention in the diagnosis and treatment of the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"627"}}